Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 24, 2025 08:00 ET | Source: Chemomab Therapeutics Ltd.

Chemomab to Participate in Oppenheimer’s Movers in Rare Disease Summit

CEO Dr. Adi Mor will present a corporate overview and meet with investors at Oppenheimer's Movers in Rare Disease Summit on Dec. 11, 2025 in NYC.